TA
XBI icon

Thor Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Thor Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,400
Closed -$107K – 259
2019
Q3 		$107K Buy
+1,400
New +$116K 0.12% 177

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Thor Advisors's XBI Position: Q4 2019 in Review

Thor Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 1,400 shares — an estimated $107K sold.

Thor Advisors first reported a position in XBI in Q3 2019 and held it in 1 quarter. The position peaked at $107K in Q3 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

  • Thor Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
  • Thor Advisors sold 1,400 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $107K.
  • Thor Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 1 quarter.
  • Thor Advisors's State Street SPDR S&P Biotech ETF position peaked at $107K in Q3 2019.
  • 474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Thor Advisors's 13F filing for Q4 2019, filed 18 Feb 2020.